Letters, Testimony & Filings

Product Recalls: February 12, 2026 – March 11, 2026

April 1, 2026

Letters, Testimony & Filings

Outrage of the Month: Chaos and Dysfunction at the Food and Drug Administration

April 1, 2026

Press Releases

FDA’s Avacopan Alert Raises More Questions Than It Answers

March 31, 2026

Press Releases

Gilead Refuses to sell Doctors without Borders HIV Drug

March 30, 2026

Letter to the Delegation of Colombia to the WTO’s 14th Ministerial Conference (MC14)

March 28, 2026

Letters, Testimony & Filings

Mpox, opacity and the need for access obligations in pandemic prevention, preparedness and response

March 25, 2026

Fact Sheets & Backgrounders

Fact Sheet: Making Medicine Affordable

March 24, 2026

Letters, Testimony & Filings

Statement to the 6th IGWG on WHO Pandemic Agreement

March 23, 2026

Letters, Testimony & Filings

Presentation at the FDA’s Virtual Listening Session With Antidepressant Petitioners

March 23, 2026